World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

A NOVEL STUDY FOR THE DETECTION OF PROGRAMMED CELL DEATH-1 GENE VARIANTS USED IN PATHOGENESIS AND CONSEQUENCES OF PCOS IN IRAQI OBESE WOMEN

Hiba Aqeel Muslem Al-Quraishy*, Hanaa Addai Ali, Maha Mohammed Kadhim Al-Tu’m and Fadhil Jawad Al-Tu’ma

ABSTRACT

Background: Apoptosis is a kind of programmed cell death that take place within the granulosa cells of ovary, is an essential part of folliculogenesis. So there is greater incidence of apoptosis in polycystic ovary syndrome women. Programmed cell death 1 PDCD1 play important negative regulatory roles in inflammation. A genetic mutation in PD-1 is associated with the incidence and progression of PCOS. Objective: To study the genetic polymorphism of PD-1gene (rs2227982) in Iraqi women with PCOS and explore its role in pathogenesis of the PCOS disease. Materials and Methods: Whole blood samples of 80 PCOS obese patients and 80 healthy people were collected in duration from Dec., 2021 to April, 2022, at the gynecological and obstetric teaching hospital, Kerbala health directorate, Iraq. The Rotterdam criteria-2003 was accepted to PCOS females with age range between (18-40 years). Patients with any 2 of the next 3 items can be identified as PCOS: oligo menorrhea / amenorrhea, increase androgen level, ovarian volume >10mL on U/S, and follicles ?12 with diameter 2-9 mm. Controller group with ages between (18-40 year). They have regular menstruation, with normal ovaries as they were accepted by the gynecologist. BMI and WHR and hormonal status were determined. DNA was extracted and stored at -20 oC until use. Primers designed for PDCD-1gene (rs2227982) based on NCBI database. Genotypes detected using the Taq Man allelic discrimination real-time PCR method. Results: The obese PCOS women had a seriously higher frequency of the PDCD-1 GA/GG genotypes (rs2227982) compared with the controls. PD-1(rs2227982) GA genotype significantly associated together with a higher PCOS frequency. P-value (0.0151), OR (2.728) and PDCD-1gene allele frequencies (rs2227982). An allele had significance P-value (0.0237), OR (2.393) with PCOS patient. Conclusion: Our findings indicates that the PDCD1 (rs2227982) genotype GA is associated with a susceptibility to obese PCOS women and affect the clinical features and pathogenesis. It may be new possible polymorphic loci for PCOS development.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR